(Q37369840)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19720923%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19720923%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

main subject

patient

0 references

metastatic breast cancer

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19720923%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Mary L Disis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19720923%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Danelle R Wallace

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19720923%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Theodore A Gooley

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19720923%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Yushe Dang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19720923%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Hailing Lu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19720923%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Andrew L Coveler

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19720923%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Jennifer S Childs

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19720923%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Doreen M Higgins

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19720923%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Patricia A Fintak

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19720923%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Corazon dela Rosa

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19720923%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Kathleen Tietje

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19720923%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

John Link

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19720923%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

James Waisman

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19720923%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Lupe G Salazar

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19720923%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

language of work or name

English

0 references

publication date

31 August 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19720923%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Oncology

6 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19720923%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19720923%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19720923%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

4685-4692

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19720923%20AND%20SRC:MED&resulttype=core&format=json

Insulin-like growth factor-binding protein-2 is a target for the immunomodulation of breast cancer

6 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754913

Tumor-induced immune suppression of in vivo effector T-cell priming is mediated by the B7-H1/PD-1 axis and transforming growth factor beta

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754913

TGF-beta and tumors--an ill-fated alliance

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754913

Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754913

Antibody-enhanced cross-presentation of self antigen breaks T cell tolerance

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754913

A clinical development paradigm for cancer vaccines and related biologics

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754913

HER-2-positive metastatic breast cancer: optimizing trastuzumab-based therapy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754913

Cooperation between CD4+ and CD8+ T cells: when, where, and how.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754913

Antigen processing by autoreactive B cells promotes determinant spreading

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754913

Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754913

Autoantibody profiling for the study and treatment of autoimmune disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754913

Epitope spreading in immune-mediated diseases: implications for immunotherapy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754913

Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754913

Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754913

Circulating transforming growth factor-beta-1 and breast cancer prognosis: results from the Shanghai Breast Cancer Study.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754913

Kinetics of tumor-specific T-cell response development after active immunization in patients with HER-2/neu overexpressing cancers.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754913

Tumor antigen-specific T-cell expansion is greatly facilitated by in vivo priming.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754913

Maximizing the retention of antigen specific lymphocyte function after cryopreservation.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754913

Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754913

Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2754913

Pre-existent immunity to the HER-2/neu oncogenic protein in patients with HER-2/neu overexpressing breast and ovarian cancer

3 December 2018

1 reference

12 December 2020

Generation of T-cell immunity to the HER-2/neu protein after active immunization with HER-2/neu peptide-based vaccines

1 reference

12 December 2020

Immunization of cancer patients with HER-2/neu-derived peptides demonstrating high-affinity binding to multiple class II alleles

1 reference

12 December 2020

Long-term cardiac tolerability of trastuzumab in metastatic breast cancer: the M.D. Anderson Cancer Center experience

1 reference

12 December 2020

Augmented HER-2 specific immunity during treatment with trastuzumab and chemotherapy

1 reference

12 December 2020

A phase II study of trastuzumab and capecitabine for patients with HER2-overexpressing metastatic breast cancer: Japan Breast Cancer Research Network (JBCRN) 00 Trial

1 reference

12 December 2020

Identifiers

DOI

10.1200/JCO.2008.20.6789

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19720923%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19720923%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

PubMed publication ID

19720923

1 reference